Скачать или смотреть What role does cfDNA have as a biomarker to monitor brain tumors?

Cecile Riviere-Cazaux, PhD, Mayo Clinic, Rochester, MN, describes the potential of cell-free DNA (cfDNA) as a biomarker for monitoring brain tumors, particularly in patients undergoing chemoradiation or immunotherapy. cfDNA has shown to be promising in tracking disease response and identifying progression versus pseudoprogression, and longitudinal sampling of cerebrospinal fluid (CSF) and plasma has also shown encouraging results in detecting changes in tumor burden and mutation frequencies. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.